Form 8-K - Current report:
SEC Accession No. 0001144204-17-052859
Filing Date
2017-10-17
Accepted
2017-10-17 17:02:59
Documents
5
Period of Report
2017-10-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tv476994_8k.htm 8-K 18399
2 EXHIBIT 1.1 tv476994_ex1-1.htm EX-1.1 240356
3 EXHIBIT 5.1 tv476994_ex5-1.htm EX-5.1 8878
4 EXHIBIT 99.1 tv476994_ex99-1.htm EX-99.1 9856
5 GRAPHIC image_001.jpg GRAPHIC 4139
  Complete submission text file 0001144204-17-052859.txt   284797
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 171141154
SIC: 2834 Pharmaceutical Preparations